Meritage Portfolio Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,020	Closed	-$338K	–	337
2021 Q3	$338K	Buy	3,020 +353	+13%	+$39.5K	0.02%	235
2021 Q2	$432K	Buy	2,667 +308	+13%	+$49.9K	0.03%	229
2021 Q1	$287K	Buy	2,359 +823	+54%	+$100K	0.02%	240
2020 Q4	$235K	Buy	+1,536	New	+$235K	0.02%	241